357 related articles for article (PubMed ID: 16116101)
1. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.
Matsuyama S; Ujike M; Morikawa S; Tashiro M; Taguchi F
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12543-7. PubMed ID: 16116101
[TBL] [Abstract][Full Text] [Related]
2. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
4. The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species.
Niemeyer D; Mösbauer K; Klein EM; Sieberg A; Mettelman RC; Mielech AM; Dijkman R; Baker SC; Drosten C; Müller MA
PLoS Pathog; 2018 Sep; 14(9):e1007296. PubMed ID: 30248143
[TBL] [Abstract][Full Text] [Related]
5. Quantifying the effect of trypsin and elastase on in vitro SARS-CoV infections.
Rodriguez T; Dobrovolny HM
Virus Res; 2021 Jul; 299():198423. PubMed ID: 33845063
[TBL] [Abstract][Full Text] [Related]
6. Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.
Castaño-Rodriguez C; Honrubia JM; Gutiérrez-Álvarez J; DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Fernandez-Delgado R; Verdia-Báguena C; Queralt-Martín M; Kochan G; Perlman S; Aguilella VM; Sola I; Enjuanes L
mBio; 2018 May; 9(3):. PubMed ID: 29789363
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal Proteases Are a Determinant of Coronavirus Tropism.
Zheng Y; Shang J; Yang Y; Liu C; Wan Y; Geng Q; Wang M; Baric R; Li F
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258004
[TBL] [Abstract][Full Text] [Related]
8. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
[TBL] [Abstract][Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.
Sims AC; Burkett SE; Yount B; Pickles RJ
Virus Res; 2008 Apr; 133(1):33-44. PubMed ID: 17451829
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.
Wang SF; Tseng SP; Yen CH; Yang JY; Tsao CH; Shen CW; Chen KH; Liu FT; Liu WT; Chen YM; Huang JC
Biochem Biophys Res Commun; 2014 Aug; 451(2):208-14. PubMed ID: 25073113
[TBL] [Abstract][Full Text] [Related]
12. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.
Spiegel M; Pichlmair A; Mühlberger E; Haller O; Weber F
J Clin Virol; 2004 Jul; 30(3):211-3. PubMed ID: 15135736
[TBL] [Abstract][Full Text] [Related]
13. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
Yamamoto N; Yang R; Yoshinaka Y; Amari S; Nakano T; Cinatl J; Rabenau H; Doerr HW; Hunsmann G; Otaka A; Tamamura H; Fujii N; Yamamoto N
Biochem Biophys Res Commun; 2004 Jun; 318(3):719-25. PubMed ID: 15144898
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication.
Zhang L; Zhang ZP; Zhang XE; Lin FS; Ge F
J Virol; 2010 Jun; 84(12):6050-9. PubMed ID: 20392858
[TBL] [Abstract][Full Text] [Related]
15. Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.
Nagata N; Iwata N; Hasegawa H; Fukushi S; Yokoyama M; Harashima A; Sato Y; Saijo M; Morikawa S; Sata T
J Virol; 2007 Feb; 81(4):1848-57. PubMed ID: 17151094
[TBL] [Abstract][Full Text] [Related]
16. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice.
Ami Y; Nagata N; Shirato K; Watanabe R; Iwata N; Nakagaki K; Fukushi S; Saijo M; Morikawa S; Taguchi F
Microbiol Immunol; 2008 Feb; 52(2):118-27. PubMed ID: 18380809
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.
Simmons G; Gosalia DN; Rennekamp AJ; Reeves JD; Diamond SL; Bates P
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11876-81. PubMed ID: 16081529
[TBL] [Abstract][Full Text] [Related]
18. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.
Jaume M; Yip MS; Cheung CY; Leung HL; Li PH; Kien F; Dutry I; Callendret B; Escriou N; Altmeyer R; Nal B; Daëron M; Bruzzone R; Peiris JS
J Virol; 2011 Oct; 85(20):10582-97. PubMed ID: 21775467
[TBL] [Abstract][Full Text] [Related]
19. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
[TBL] [Abstract][Full Text] [Related]
20. Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.
Venkataraman T; Coleman CM; Frieman MB
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
